| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF502 NCOA2 ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 PEG3 ZNF813 ZNF510 ZNF229 ZNF260 ZNF518A ZNF430 ZNF23 MTA1 ZNF28 ZNF33A ZNF852 GLI3 ZNF888 ZNF761 ZNF860 ZNF615 ZNF85 ZNF681 ZNF662 | 1.38e-06 | 1459 | 135 | 27 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF502 ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 PEG3 ZNF813 ZNF510 ZNF229 ZNF260 ZNF518A ZNF430 ZNF23 ZNF28 ZNF33A ZNF852 GLI3 ZNF888 ZNF761 ZNF860 ZNF615 ZNF85 MYRF ZNF681 | 7.91e-06 | 1412 | 135 | 25 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF502 NCOA2 ZNF845 ZNF680 ZNF569 ZNF268 ZNF813 ZNF229 ZNF260 ZNF430 ZNF23 MTA1 ZNF28 ZNF33A ZNF852 GLI3 ZNF888 ZNF761 ZNF860 ZNF615 ZNF85 ZNF681 ZNF662 | 9.66e-06 | 1244 | 135 | 23 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF502 NCOA2 ZNF845 ZNF680 ZNF569 ZNF268 ZNF813 ZNF229 ZNF260 ZNF430 ZNF23 MTA1 ZNF28 ZNF33A ZNF852 GLI3 ZNF888 ZNF761 ZNF860 ZNF615 ZNF85 ZNF681 ZNF662 | 1.37e-05 | 1271 | 135 | 23 | GO:0000987 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | NPHS1 RPL24 COMP ADAM18 ADAM9 EIF3E ARFIP2 FMNL2 GFRA1 SVEP1 ASAP1 PTPRJ ICAM5 MACF1 | 5.58e-05 | 599 | 135 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.20e-04 | 279 | 135 | 9 | GO:0005096 | |
| GeneOntologyMolecularFunction | mediator complex binding | 2.70e-04 | 4 | 135 | 2 | GO:0036033 | |
| GeneOntologyMolecularFunction | histone H4 demethylase activity | 4.48e-04 | 5 | 135 | 2 | GO:0141058 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RANBP2 BCAS3 PREX2 ASAP1 DOCK5 ARHGAP5 ASAP2 PPP2R5C PPP2R5D PLAA TBC1D1 GNB5 ARHGAP29 | 5.13e-04 | 656 | 135 | 13 | GO:0008047 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RANBP2 MYCBP2 DOCK11 PREX2 ASAP1 DOCK5 ARHGAP5 ASAP2 TBC1D1 GNB5 ARHGAP29 | 6.70e-04 | 507 | 135 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RANBP2 MYCBP2 DOCK11 PREX2 ASAP1 DOCK5 ARHGAP5 ASAP2 TBC1D1 GNB5 ARHGAP29 | 6.70e-04 | 507 | 135 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | integrin binding | 1.23e-03 | 175 | 135 | 6 | GO:0005178 | |
| MousePheno | decreased corpus callosum size | 2.05e-05 | 47 | 100 | 5 | MP:0000781 | |
| MousePheno | abnormal corpus callosum size | 3.37e-05 | 52 | 100 | 5 | MP:0020573 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF502 TRERF1 ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 PEG3 ZNF813 ZNF510 ZNF229 ZNF230 ZNF285 ZNF260 ZNF518A ZNF430 ZNF23 ZNF28 ZNF33A ZNF852 GLI3 ZNF761 ZNF860 ZNF615 ZNF85 ZNF654 ZNF681 ZNF662 | 9.05e-14 | 694 | 135 | 28 | IPR013087 |
| Domain | KRAB | ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 ZNF813 ZNF510 ZNF229 ZNF230 ZNF285 ZNF430 ZNF23 ZNF28 ZNF33A ZNF852 ZNF761 ZNF860 ZNF615 ZNF85 ZNF681 ZNF662 | 1.36e-13 | 358 | 135 | 21 | PS50805 |
| Domain | KRAB | ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 ZNF813 ZNF510 ZNF229 ZNF230 ZNF285 ZNF430 ZNF23 ZNF28 ZNF33A ZNF852 ZNF761 ZNF860 ZNF615 ZNF85 ZNF681 ZNF662 | 2.45e-13 | 369 | 135 | 21 | SM00349 |
| Domain | KRAB | ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 ZNF813 ZNF510 ZNF229 ZNF230 ZNF285 ZNF430 ZNF23 ZNF28 ZNF33A ZNF852 ZNF761 ZNF860 ZNF615 ZNF85 ZNF681 ZNF662 | 2.58e-13 | 370 | 135 | 21 | IPR001909 |
| Domain | - | ZNF502 TRERF1 ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 PEG3 ZNF813 ZNF510 ZNF229 ZNF230 ZNF285 ZNF260 ZNF430 ZNF23 ZNF28 ZNF33A ZNF852 GLI3 ZNF761 ZNF860 ZNF615 ZNF85 ZNF654 ZNF681 ZNF662 | 3.78e-13 | 679 | 135 | 27 | 3.30.160.60 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF502 TRERF1 ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 PEG3 ZNF813 ZNF510 ZNF229 ZNF230 ZNF285 ZNF260 ZNF518A ZNF430 ZNF23 ZNF28 ZNF33A ZNF852 GLI3 ZNF761 ZNF860 ZNF615 ZNF85 ZNF654 ZNF681 ZNF662 | 1.33e-12 | 775 | 135 | 28 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF502 TRERF1 ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 PEG3 ZNF813 ZNF510 ZNF229 ZNF230 ZNF285 ZNF260 ZNF518A ZNF430 ZNF23 ZNF28 ZNF33A ZNF852 GLI3 ZNF761 ZNF860 ZNF615 ZNF85 ZNF654 ZNF681 ZNF662 | 1.41e-12 | 777 | 135 | 28 | PS00028 |
| Domain | Znf_C2H2-like | ZNF502 TRERF1 ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 PEG3 ZNF813 ZNF510 ZNF229 ZNF230 ZNF285 ZNF260 ZNF518A ZNF430 ZNF23 ZNF28 ZNF33A ZNF852 GLI3 ZNF761 ZNF860 ZNF615 ZNF85 ZNF654 ZNF681 ZNF662 | 2.52e-12 | 796 | 135 | 28 | IPR015880 |
| Domain | Znf_C2H2 | ZNF502 TRERF1 ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 PEG3 ZNF813 ZNF510 ZNF229 ZNF230 ZNF285 ZNF260 ZNF518A ZNF430 ZNF23 ZNF28 ZNF33A ZNF852 GLI3 ZNF761 ZNF860 ZNF615 ZNF85 ZNF654 ZNF681 ZNF662 | 3.29e-12 | 805 | 135 | 28 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF502 TRERF1 ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 PEG3 ZNF813 ZNF510 ZNF229 ZNF230 ZNF285 ZNF260 ZNF518A ZNF430 ZNF23 ZNF28 ZNF33A ZNF852 GLI3 ZNF761 ZNF860 ZNF615 ZNF85 ZNF654 ZNF681 ZNF662 | 3.60e-12 | 808 | 135 | 28 | SM00355 |
| Domain | zf-C2H2 | ZNF502 TRERF1 ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 PEG3 ZNF813 ZNF510 ZNF229 ZNF230 ZNF285 ZNF260 ZNF518A ZNF430 ZNF23 ZNF28 ZNF33A ZNF852 ZNF761 ZNF860 ZNF615 ZNF85 ZNF681 ZNF662 | 4.10e-12 | 693 | 135 | 26 | PF00096 |
| Domain | KRAB | ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 ZNF813 ZNF510 ZNF229 ZNF230 ZNF285 ZNF430 ZNF28 ZNF33A ZNF852 ZNF761 ZNF860 ZNF615 ZNF85 ZNF681 | 1.25e-11 | 358 | 135 | 19 | PF01352 |
| Domain | zf-C2H2_6 | ZNF502 TRERF1 ZNF845 ZNF680 ZNF569 PEG3 ZNF813 ZNF229 ZNF260 ZNF852 ZNF761 ZNF860 ZNF615 ZNF85 ZNF681 | 8.69e-09 | 314 | 135 | 15 | PF13912 |
| Domain | ARM-type_fold | CLTCL1 DOCK11 FRYL FMNL2 DOCK5 PPP2R5C PPP2R5D PLAA PIK3C2G ASPM ULK4 ATM NIPBL | 1.10e-06 | 339 | 135 | 13 | IPR016024 |
| Domain | ELM2_dom | 1.00e-04 | 13 | 135 | 3 | IPR000949 | |
| Domain | ELM2 | 1.00e-04 | 13 | 135 | 3 | PF01448 | |
| Domain | ELM2 | 1.00e-04 | 13 | 135 | 3 | PS51156 | |
| Domain | ELM2 | 1.00e-04 | 13 | 135 | 3 | SM01189 | |
| Domain | HMGL-like | 1.55e-04 | 3 | 135 | 2 | PF00682 | |
| Domain | PYR_CT | 1.55e-04 | 3 | 135 | 2 | PS50991 | |
| Domain | PYR_CT | 1.55e-04 | 3 | 135 | 2 | IPR000891 | |
| Domain | PP2A_B56 | 5.11e-04 | 5 | 135 | 2 | IPR002554 | |
| Domain | B56 | 5.11e-04 | 5 | 135 | 2 | PF01603 | |
| Domain | SANT_dom | 8.50e-04 | 26 | 135 | 3 | IPR017884 | |
| Domain | SANT | 1.06e-03 | 28 | 135 | 3 | PS51293 | |
| Domain | AH/BAR-dom | 1.30e-03 | 30 | 135 | 3 | IPR027267 | |
| Domain | - | 1.30e-03 | 30 | 135 | 3 | 1.20.1270.60 | |
| Pubmed | NCOA2 MAPK8IP1 AHCYL1 MYCBP2 ZCCHC8 ADAM9 SPTB HSPH1 PEG3 FMNL2 WDR59 JAK1 ARHGAP5 MTA1 MTA3 TRIM8 LRP1 BTG3 MACF1 ATM PC NIPBL ZNF662 | 1.10e-09 | 1285 | 136 | 23 | 35914814 | |
| Pubmed | ZNF845 ZNF680 ZNF569 ZCCHC8 ZNF813 ZNF229 ZNF430 ZNF33A ZNF615 ZNF681 | 2.74e-09 | 181 | 136 | 10 | 37372979 | |
| Pubmed | THSD7A MYCBP2 ZCCHC8 EIF3E ZNF510 FMNL2 DDB1 SVEP1 ZNF518A ARHGAP5 TBC1D1 LRP1 MACF1 | 6.21e-07 | 591 | 136 | 13 | 15231748 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 MYCBP2 BCAS3 ZNF875 SPTB FRYL IDE DOCK5 CFAP20DC ASAP2 ZNF33A MTA3 PTPRJ TBC1D1 LRP1 MACF1 CAMKMT PISD SEMA6A ANKRD12 | 1.46e-06 | 1489 | 136 | 20 | 28611215 |
| Pubmed | 1.82e-06 | 282 | 136 | 9 | 23667531 | ||
| Pubmed | RANBP2 MYCBP2 SPTB PEG3 CHORDC1 SUCLG2 ASAP1 ZNF23 PDLIM3 MACF1 NOSTRIN | 4.45e-06 | 497 | 136 | 11 | 23414517 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF845 ZNF680 ATAD5 SMC6 ZNF813 PHF8 DDB1 FSIP2 LIG3 MTA1 MTA3 NIPBL | 5.19e-06 | 608 | 136 | 12 | 36089195 |
| Pubmed | 1.25e-05 | 12 | 136 | 3 | 20720167 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 22508697 | ||
| Pubmed | Genetic Variants in LRP1 and ULK4 Are Associated with Acute Aortic Dissections. | 1.52e-05 | 2 | 136 | 2 | 27569546 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 19363681 | ||
| Pubmed | Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system. | 1.52e-05 | 2 | 136 | 2 | 25319202 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 16855396 | ||
| Pubmed | Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia. | 1.52e-05 | 2 | 136 | 2 | 24342190 | |
| Pubmed | TRERF1 NCOA2 MAPK8IP1 RANBP2 MYCBP2 CENPF DOCK11 ADAM9 DDB1 PPP2R5D ICAM5 LRP1 MACF1 NIPBL | 2.64e-05 | 963 | 136 | 14 | 28671696 | |
| Pubmed | 3.16e-05 | 16 | 136 | 3 | 24744753 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RANBP2 HSPH1 PHF8 CHORDC1 ARFIP2 DDB1 ASAP1 ARHGAP5 PPP2R5D PDLIM3 TBC1D1 ARHGAP29 PC | 3.21e-05 | 853 | 136 | 13 | 28718761 |
| Pubmed | ATAD5 ZCCHC8 PHF8 FMNL2 DDB1 ZNF518A JAK1 MTA1 MTA3 JMJD6 GLI3 ASPM LRP1 TEKT1 MACF1 | 3.32e-05 | 1116 | 136 | 15 | 31753913 | |
| Pubmed | UBE2O and USP7 co-regulate RECQL4 ubiquitinylation and homologous recombination-mediated DNA repair. | 3.47e-05 | 155 | 136 | 6 | 34921745 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | CCP110 MYCBP2 CENPF ADAM9 MKRN2 EIF3E IDE CHORDC1 DDB1 WDR59 PLAA MRPL11 | 4.33e-05 | 754 | 136 | 12 | 33060197 |
| Pubmed | 4.44e-05 | 162 | 136 | 6 | 15174051 | ||
| Pubmed | TRERF1 NCOA2 RPL24 AHCYL1 ATAD5 HSPH1 EIF3E PHF8 DDB1 ZNF260 LIG3 MTA1 MTA3 GLI3 SUGP1 MRPL11 NIPBL | 4.49e-05 | 1429 | 136 | 17 | 35140242 | |
| Pubmed | Identification and characterization of metastasis-associated gene/protein 1 (MTA1). | 4.54e-05 | 3 | 136 | 2 | 25315816 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 26869315 | ||
| Pubmed | MTA1, a transcriptional activator of breast cancer amplified sequence 3. | 4.54e-05 | 3 | 136 | 2 | 16617102 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 25972378 | ||
| Pubmed | Homozygous loss-of-function mutations in FSIP2 cause male infertility with asthenoteratospermia. | 4.54e-05 | 3 | 136 | 2 | 30745215 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 15051958 | ||
| Pubmed | RANBP2 MYCBP2 CENPF ZCCHC8 EIF3E FRYL DDB1 PREP MACF1 ATM NIPBL | 5.50e-05 | 653 | 136 | 11 | 22586326 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 6.24e-05 | 341 | 136 | 8 | 32971831 | |
| Pubmed | 6.35e-05 | 20 | 136 | 3 | 12743021 | ||
| Pubmed | AHCYL1 DOCK11 DDB1 WDR59 PREX2 ASAP1 DOCK5 ARHGAP5 ASAP2 PPP2R5C MTA1 ARHGAP29 MRPL11 | 6.63e-05 | 916 | 136 | 13 | 32203420 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | AHCYL1 ADAM9 HSPH1 SMC6 FBXO46 DOCK5 JAK1 PTPRJ MACF1 PISD ATM PC MYRF CD99L2 | 7.49e-05 | 1061 | 136 | 14 | 33845483 |
| Pubmed | 7.52e-05 | 57 | 136 | 4 | 36849460 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL24 RANBP2 AHCYL1 MYCBP2 HSPH1 EIF3E PHF8 SUCLG2 DDB1 WDR59 ASAP1 LIG3 PLAA ASPM MACF1 NIPBL | 8.19e-05 | 1353 | 136 | 16 | 29467282 |
| Pubmed | 8.30e-05 | 457 | 136 | 9 | 22190034 | ||
| Pubmed | TRERF1 NCOA2 ZNF569 MKRN2 PEG3 PHF8 ZNF260 MTA3 JMJD6 GLI3 ZNF654 ZNF681 | 8.35e-05 | 808 | 136 | 12 | 20412781 | |
| Pubmed | Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1. | 9.06e-05 | 4 | 136 | 2 | 18056802 | |
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 14729961 | ||
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 12149250 | ||
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 15647754 | ||
| Pubmed | NCOA2 ZNF569 HSPH1 PEG3 SMC6 FRYL CPT2 ASAP1 ARHGAP5 PPP2R5C MTA1 PLAA MACF1 ANKRD12 | 9.39e-05 | 1084 | 136 | 14 | 11544199 | |
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 16502042 | ||
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 8812429 | ||
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 15095873 | ||
| Pubmed | A-kinase anchoring protein 4 binding proteins in the fibrous sheath of the sperm flagellum. | 1.51e-04 | 5 | 136 | 2 | 12606363 | |
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 27806302 | ||
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 25487150 | ||
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 31036553 | ||
| Pubmed | Mutations in tap uncouple RNA export activity from translocation through the nuclear pore complex. | 1.51e-04 | 5 | 136 | 2 | 16314397 | |
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 11483358 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCP110 MYCBP2 DOCK11 ZCCHC8 BCAS3 FRYL WDR59 FSIP2 TBC1D1 MACF1 PC MUSK | 1.51e-04 | 861 | 136 | 12 | 36931259 |
| Pubmed | 1.60e-04 | 27 | 136 | 3 | 18685082 | ||
| Pubmed | RPL24 CCP110 AHCYL1 CLTCL1 HSPH1 EIF3E PHF8 DDB1 ASAP2 MTA1 MTA3 RBMS3 MACF1 MRPL11 | 1.78e-04 | 1153 | 136 | 14 | 29845934 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RANBP2 CENPF SMC6 EIF3E IDE CHORDC1 DDB1 PPP2R5C PPP2R5D PLAA ASPM BTG3 ATM NIPBL | 1.81e-04 | 1155 | 136 | 14 | 20360068 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RPL24 AHCYL1 HSPH1 EIF3E FRYL IDE CHORDC1 ARFIP2 DDB1 DENR PPP2R5C PPP2R5D PLAA MTA3 JMJD6 MACF1 | 1.88e-04 | 1455 | 136 | 16 | 22863883 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MYCBP2 CENPF ATAD5 SMC6 EIF3E ATG14 PHF8 DDB1 LIG3 ASPM MACF1 | 2.05e-04 | 759 | 136 | 11 | 35915203 |
| Pubmed | 2.10e-04 | 407 | 136 | 8 | 12693553 | ||
| Pubmed | AHCYL1 COMP HSPH1 SMC6 WDR59 PREX2 TAS2R42 PPP2R5C JMJD6 GLI3 GNB5 ASPM SUGP1 PC NIPBL | 2.25e-04 | 1327 | 136 | 15 | 32694731 | |
| Pubmed | 2.25e-04 | 6 | 136 | 2 | 34259627 | ||
| Pubmed | A family of cellular proteins related to snake venom disintegrins. | 2.25e-04 | 6 | 136 | 2 | 8146185 | |
| Pubmed | Exploring genome-wide - dietary heme iron intake interactions and the risk of type 2 diabetes. | 2.25e-04 | 6 | 136 | 2 | 23386860 | |
| Pubmed | SLX4-SLX1 Protein-independent Down-regulation of MUS81-EME1 Protein by HIV-1 Viral Protein R (Vpr). | 2.25e-04 | 6 | 136 | 2 | 27354282 | |
| Pubmed | 2.25e-04 | 6 | 136 | 2 | 22383525 | ||
| Pubmed | 2.25e-04 | 6 | 136 | 2 | 18786926 | ||
| Pubmed | 2.43e-04 | 31 | 136 | 3 | 29846670 | ||
| Pubmed | 2.49e-04 | 222 | 136 | 6 | 37071664 | ||
| Pubmed | FBXO38 Ubiquitin Ligase Controls Centromere Integrity via ZXDA/B Stability. | 2.67e-04 | 32 | 136 | 3 | 35813202 | |
| Pubmed | 2.68e-04 | 225 | 136 | 6 | 12168954 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZNF502 RANBP2 ZNF845 ADAM9 SMC6 EIF3E ZNF813 ZNF260 ZNF518A PPP2R5C ZNF28 PPP2R5D GLI3 LRP1 | 2.74e-04 | 1203 | 136 | 14 | 29180619 |
| Pubmed | DNA repair gene polymorphisms and risk of pancreatic cancer. | 3.15e-04 | 7 | 136 | 2 | 19147782 | |
| Pubmed | 3.15e-04 | 7 | 136 | 2 | 8703017 | ||
| Pubmed | Genome-Wide Analysis in Brazilians Reveals Highly Differentiated Native American Genome Regions. | 3.15e-04 | 7 | 136 | 2 | 28100790 | |
| Pubmed | 3.15e-04 | 7 | 136 | 2 | 24528857 | ||
| Pubmed | 3.15e-04 | 7 | 136 | 2 | 9819391 | ||
| Pubmed | Cep78 controls centrosome homeostasis by inhibiting EDD-DYRK2-DDB1VprBP. | 3.15e-04 | 7 | 136 | 2 | 28242748 | |
| Pubmed | CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. | 3.15e-04 | 7 | 136 | 2 | 17255943 | |
| Pubmed | ATM-mediated phosphorylation activates the tumor-suppressive function of B56γ-PP2A. | 3.15e-04 | 7 | 136 | 2 | 21460856 | |
| Pubmed | 3.15e-04 | 7 | 136 | 2 | 2850480 | ||
| Pubmed | Identification of a new family of protein phosphatase 2A regulatory subunits. | 3.15e-04 | 7 | 136 | 2 | 7592815 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RPL24 RANBP2 ATAD5 ZCCHC8 HSPH1 DDB1 LIG3 PDLIM3 SUGP1 MACF1 PC NIPBL | 3.17e-04 | 934 | 136 | 12 | 33916271 |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 3.19e-04 | 150 | 136 | 5 | 28242625 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 3.50e-04 | 153 | 136 | 5 | 26365490 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 3.99e-04 | 565 | 136 | 9 | 25468996 | |
| Pubmed | 4.12e-04 | 244 | 136 | 6 | 30349055 | ||
| Pubmed | Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. | 4.19e-04 | 8 | 136 | 2 | 15719014 | |
| Pubmed | 4.19e-04 | 8 | 136 | 2 | 18067919 | ||
| Pubmed | DNA damage repair machinery and HIV escape from innate immune sensing. | 4.19e-04 | 8 | 136 | 2 | 24795708 | |
| Pubmed | Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells. | 4.19e-04 | 8 | 136 | 2 | 26401039 | |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 4.59e-04 | 91 | 136 | 4 | 20362542 | |
| Pubmed | 4.99e-04 | 93 | 136 | 4 | 7829101 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 5.31e-04 | 256 | 136 | 6 | 33397691 | |
| Pubmed | Vpr-induced DNA double-strand breaks: molecular mechanism and biological relevance. | 5.37e-04 | 9 | 136 | 2 | 19275579 | |
| Pubmed | 5.37e-04 | 9 | 136 | 2 | 30595372 | ||
| Pubmed | RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene. | 5.37e-04 | 9 | 136 | 2 | 22926524 | |
| Pubmed | NANOS2 acts as an intrinsic regulator of gonocytes-to-spermatogonia transition in the murine testes. | 5.37e-04 | 9 | 136 | 2 | 29339164 | |
| Pubmed | 5.37e-04 | 9 | 136 | 2 | 23986861 | ||
| Pubmed | A common coding variant in CASP8 is associated with breast cancer risk. | 5.37e-04 | 9 | 136 | 2 | 17293864 | |
| Pubmed | 5.37e-04 | 9 | 136 | 2 | 26028330 | ||
| Pubmed | 5.37e-04 | 9 | 136 | 2 | 15184363 | ||
| Interaction | TRIM28 interactions | RPL24 RANBP2 ZNF845 ZNF680 MYCBP2 CENPF ZNF569 ZNF268 ZCCHC8 HSPH1 ZNF813 ZNF229 SUCLG2 DDB1 ZNF518A ZNF430 ZNF28 ZNF33A ZNF888 ZNF761 ZNF615 ZNF85 ATM PC DNAH8 MRPL11 NIPBL ZNF681 | 4.16e-07 | 1474 | 135 | 28 | int:TRIM28 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | NPHS1 ZNF845 ZNF569 ZNF875 PEG3 ZNF813 ZNF229 ZNF230 ZNF285 ELSPBP1 FBXO46 ZNF260 ITPKC ZNF28 ZNF888 ZNF761 ZNF615 NLRP8 | 1.73e-08 | 1192 | 136 | 18 | chr19q13 |
| Cytoband | 2p24.2 | 3.86e-04 | 10 | 136 | 2 | 2p24.2 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF502 ZNF845 ZNF680 ZNF569 ZNF268 ZNF875 PEG3 ZNF813 ZNF510 ZNF229 ZNF230 ZNF285 ZNF260 ZNF518A ZNF430 ZNF23 ZNF28 ZNF33A ZNF852 GLI3 ZNF888 ZNF761 ZNF860 ZNF615 ZNF85 ZNF681 ZNF662 | 2.73e-16 | 718 | 95 | 27 | 28 |
| GeneFamily | PHD finger proteins|NuRD complex | 1.74e-03 | 12 | 95 | 2 | 1305 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.72e-03 | 53 | 95 | 3 | 532 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 2.74e-03 | 15 | 95 | 2 | 696 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.74e-03 | 15 | 95 | 2 | 82 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 3.53e-03 | 17 | 95 | 2 | 1291 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 5.43e-07 | 137 | 134 | 8 | M39241 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYCBP2 ZNF268 ADAM9 HSPH1 SMC6 EIF3E CHORDC1 ELSPBP1 ZNF430 ARHGAP5 ASPM ZNF85 ATM NIPBL ZNF654 | 1.41e-06 | 656 | 134 | 15 | M18979 |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE | 4.68e-06 | 84 | 134 | 6 | M40895 | |
| Coexpression | GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN | 9.16e-06 | 200 | 134 | 8 | M4108 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CCP110 ZNF845 CENPF BCAS3 STRA8 IDE PHF8 DENR ZNF518A CFAP20DC PPP2R5C PLAA MTA3 SUGP1 CAMKMT ANKRD12 ATM DNAH8 | 2.67e-06 | 820 | 130 | 18 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | NCOA2 KLHL24 AHCYL1 MYCBP2 BCAS3 IDE GFRA1 ASAP1 JAK1 LIG3 ZNF23 GLI3 | 4.49e-06 | 385 | 130 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | RANBP2 ZNF845 CENPF DOCK11 ATAD5 HSPH1 SMC6 PREX2 ZNF518A PLAA GLI3 ASPM ATM NIPBL | 4.95e-06 | 532 | 130 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | NPHS1 CCP110 ZNF845 CENPF ATAD5 HSPH1 PEG3 SMC6 EIF3E CHORDC1 ZNF260 ZNF518A ARHGAP5 ZNF23 GLI3 NXT1 ASPM ZNF888 MACF1 ZNF761 NIPBL ZNF654 | 6.17e-06 | 1241 | 130 | 22 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | TRERF1 NCOA2 RANBP2 THSD7A CENPF ATAD5 HSPH1 SMC6 FMNL2 GFRA1 ZNF23 GLI3 ASPM SEMA6A ANKRD12 | 1.16e-05 | 654 | 130 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.22e-05 | 311 | 130 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.45e-05 | 192 | 130 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | NPHS1 CCP110 ZNF845 CENPF ATAD5 HSPH1 PEG3 SMC6 EIF3E CHORDC1 PREX2 ZNF260 ZNF518A ARHGAP5 ZNF23 GLI3 NXT1 ASPM ZNF888 MACF1 ZNF761 NIPBL ZNF654 | 2.71e-05 | 1468 | 130 | 23 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | RANBP2 ZNF845 THSD7A CENPF ATAD5 HSPH1 PREX2 ZNF518A ZNF23 GLI3 ASPM NIPBL | 3.20e-05 | 469 | 130 | 12 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | NPHS1 CCP110 ZNF845 CENPF ATAD5 HSPH1 SMC6 ZNF813 ZNF260 ZNF518A ARHGAP5 ZNF23 GLI3 ASPM ZNF761 SEMA6A ANKRD12 ATM NIPBL ZNF654 | 7.46e-05 | 1252 | 130 | 20 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RANBP2 SPARC PEG3 SMC6 PREX2 ASAP1 ARHGAP5 MACF1 ANKRD12 NIPBL | 4.67e-10 | 194 | 136 | 10 | e3d63874111d1e8da3977329426e4dcf68d6de87 |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | SPARC THSD7A FMNL2 PREX2 ASAP1 ASAP2 ARHGAP29 SEMA6A NOSTRIN | 9.77e-09 | 196 | 136 | 9 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-07 | 188 | 136 | 8 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-07 | 188 | 136 | 8 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-07 | 188 | 136 | 8 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-07 | 188 | 136 | 8 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-07 | 188 | 136 | 8 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.02e-07 | 166 | 136 | 7 | f416d8a322f086c769659a9fab6b460a2d546ab1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.79e-07 | 171 | 136 | 7 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.79e-07 | 171 | 136 | 7 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-06 | 173 | 136 | 7 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-06 | 173 | 136 | 7 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-06 | 183 | 136 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-06 | 184 | 136 | 7 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.78e-06 | 187 | 136 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-06 | 191 | 136 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-06 | 191 | 136 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-06 | 192 | 136 | 7 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.12e-06 | 192 | 136 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-06 | 194 | 136 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.27e-06 | 194 | 136 | 7 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 194 | 136 | 7 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 194 | 136 | 7 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 195 | 136 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 197 | 136 | 7 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 197 | 136 | 7 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 197 | 136 | 7 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 199 | 136 | 7 | 14e09eaa2335d4503de50250eb4258dd5b85b304 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.78e-06 | 200 | 136 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.78e-06 | 200 | 136 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Tracheal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 200 | 136 | 7 | 71ba0e48ca4ded077f2b96a0cf4f2331f2e25d15 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 200 | 136 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.78e-06 | 200 | 136 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 8.55e-06 | 156 | 136 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 167 | 136 | 6 | 5c82d801e3b7d7c6c967a73b94b2ee2a8da1fd6e | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-05 | 169 | 136 | 6 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.44e-05 | 171 | 136 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.49e-05 | 172 | 136 | 6 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 176 | 136 | 6 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 176 | 136 | 6 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 176 | 136 | 6 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.81e-05 | 178 | 136 | 6 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-05 | 178 | 136 | 6 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-05 | 178 | 136 | 6 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-05 | 181 | 136 | 6 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-immature_B_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.05e-05 | 182 | 136 | 6 | ab78df9de3878a6d67106a40094c893601de8076 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.18e-05 | 184 | 136 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-05 | 186 | 136 | 6 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.32e-05 | 186 | 136 | 6 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.39e-05 | 187 | 136 | 6 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.46e-05 | 188 | 136 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.46e-05 | 188 | 136 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 189 | 136 | 6 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 189 | 136 | 6 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | Endothelial-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.54e-05 | 189 | 136 | 6 | 04b565855f58ca0f343904d04be657b66e109076 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 190 | 136 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.61e-05 | 190 | 136 | 6 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 190 | 136 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 191 | 136 | 6 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 191 | 136 | 6 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 191 | 136 | 6 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.69e-05 | 191 | 136 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-05 | 192 | 136 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 192 | 136 | 6 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-05 | 192 | 136 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-05 | 192 | 136 | 6 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-05 | 192 | 136 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.77e-05 | 192 | 136 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-05 | 192 | 136 | 6 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 192 | 136 | 6 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 2.77e-05 | 192 | 136 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-05 | 193 | 136 | 6 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.85e-05 | 193 | 136 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 193 | 136 | 6 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-05 | 193 | 136 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-05 | 193 | 136 | 6 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.85e-05 | 193 | 136 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.85e-05 | 193 | 136 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.85e-05 | 193 | 136 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 193 | 136 | 6 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-05 | 194 | 136 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-05 | 194 | 136 | 6 | 2e5b195e02dcd5e9432b9a98b22e0478e65b9ba2 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.94e-05 | 194 | 136 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.94e-05 | 194 | 136 | 6 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-05 | 194 | 136 | 6 | 1b382508453c5b08fb617f626b230adf3b6cff99 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-05 | 194 | 136 | 6 | b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.94e-05 | 194 | 136 | 6 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-05 | 194 | 136 | 6 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-05 | 194 | 136 | 6 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.94e-05 | 194 | 136 | 6 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-05 | 194 | 136 | 6 | 44c7d4b75f3b7c9301eba20610e548a01a84ae40 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-05 | 194 | 136 | 6 | fa6d51f36a3dae8763a595c20892987ed454c0f0 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-05 | 194 | 136 | 6 | 7f24023df47935286f185dd428d48797daf26f49 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-05 | 194 | 136 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.02e-05 | 195 | 136 | 6 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.02e-05 | 195 | 136 | 6 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-05 | 195 | 136 | 6 | 6bb6349d6ec8da094fe1c7c590021989337aeb0b | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-05 | 195 | 136 | 6 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-05 | 195 | 136 | 6 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 195 | 136 | 6 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| Disease | Acute necrotizing encephalopathy of childhood | 2.02e-05 | 2 | 133 | 2 | C4706387 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement | 3.92e-05 | 15 | 133 | 3 | EFO_0800508 | |
| Disease | Colorectal Carcinoma | SPARC ZNF569 PEG3 AKAP3 PREX2 LIG3 ICAM5 GLI3 GNB5 LRP1 DNAH8 NLRP8 | 8.35e-05 | 702 | 133 | 12 | C0009402 |
| Disease | response to bevacizumab, Proteinuria | 2.00e-04 | 5 | 133 | 2 | EFO_0005943, HP_0000093 | |
| Disease | dietary heme iron intake measurement, type 2 diabetes mellitus | 2.99e-04 | 6 | 133 | 2 | EFO_0008355, MONDO_0005148 | |
| Disease | 1-arachidonylglycerol (20:4) measurement | 2.99e-04 | 6 | 133 | 2 | EFO_0800224 | |
| Disease | 1-arachidonoylglycerophosphocholine measurement | 2.99e-04 | 6 | 133 | 2 | EFO_0021076 | |
| Disease | 1-linoleoylglycerophosphoethanolamine measurement | 2.99e-04 | 6 | 133 | 2 | EFO_0021084 | |
| Disease | arachidonoylcholine measurement | 2.99e-04 | 6 | 133 | 2 | EFO_0800478 | |
| Disease | lysophosphatidylcholine 18:3 measurement | 2.99e-04 | 6 | 133 | 2 | EFO_0021454 | |
| Disease | 1-docosapentaenoyl-GPC (22:5n3) measurement | 2.99e-04 | 6 | 133 | 2 | EFO_0800298 | |
| Disease | lysophosphatidylcholine 20:4 measurement | 4.04e-04 | 32 | 133 | 3 | EFO_0010363 | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 4.17e-04 | 7 | 133 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | eicosapentaenoate (EPA; 20:5n3) measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0800616 | |
| Disease | arachidonate 20:4n6 measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0021063 | |
| Disease | level of Phosphatidylcholine (18:2_20:4) in blood serum | 4.17e-04 | 7 | 133 | 2 | OBA_2045109 | |
| Disease | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0800391 | |
| Disease | level of Phosphatidylcholine (O-18:2_20:4) in blood serum | 4.17e-04 | 7 | 133 | 2 | OBA_2045135 | |
| Disease | 1-eicosapentaenoyl-GPE (20:5) measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0800353 | |
| Disease | Manic | 4.35e-04 | 78 | 133 | 4 | C0338831 | |
| Disease | hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)) measurement | 5.55e-04 | 8 | 133 | 2 | EFO_0800583 | |
| Disease | stearidonate 18:4n3 measurement | 5.55e-04 | 8 | 133 | 2 | EFO_0021075 | |
| Disease | 1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6) measurement | 5.55e-04 | 8 | 133 | 2 | EFO_0800392 | |
| Disease | level of Phosphatidylethanolamine (O-18:1_18:2) in blood serum | 5.55e-04 | 8 | 133 | 2 | OBA_2045147 | |
| Disease | level of Phosphatidylethanolamine (O-18:2_20:4) in blood serum | 5.55e-04 | 8 | 133 | 2 | OBA_2045151 | |
| Disease | 1-arachidonoyl-GPE (20:4n6) measurement | 7.11e-04 | 9 | 133 | 2 | EFO_0800248 | |
| Disease | level of Phosphatidylcholine (O-18:1_18:2) in blood serum | 7.11e-04 | 9 | 133 | 2 | OBA_2045129 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:3) in blood serum | 7.11e-04 | 9 | 133 | 2 | OBA_2045130 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) measurement | 7.11e-04 | 9 | 133 | 2 | EFO_0800271 | |
| Disease | QT interval | 7.30e-04 | 534 | 133 | 9 | EFO_0004682 | |
| Disease | cholesteryl ester 18:3 measurement | 7.83e-04 | 40 | 133 | 3 | EFO_0010346 | |
| Disease | Moyamoya disease | 7.83e-04 | 40 | 133 | 3 | MONDO_0016820 | |
| Disease | level of Phosphatidylcholine (O-18:2_16:0) in blood serum | 8.86e-04 | 10 | 133 | 2 | OBA_2045132 | |
| Disease | cholesteryl ester 22:4 measurement | 8.86e-04 | 10 | 133 | 2 | EFO_0021443 | |
| Disease | phosphatidylethanolamine ether measurement | 8.86e-04 | 10 | 133 | 2 | EFO_0010229 | |
| Disease | 3-methylglutarylcarnitine (2) measurement | 1.08e-03 | 11 | 133 | 2 | EFO_0800074 | |
| Disease | level of Phosphatidylcholine (O-16:1_20:4) in blood serum | 1.08e-03 | 11 | 133 | 2 | OBA_2045123 | |
| Disease | Malignant neoplasm of breast | TRERF1 NCOA2 CENPF ZNF569 SMC6 JMJD6 ICAM5 ARHGAP29 MACF1 ATM SPOCD1 NIPBL NLRP8 | 1.16e-03 | 1074 | 133 | 13 | C0006142 |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 1.29e-03 | 12 | 133 | 2 | EFO_0800500 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:3) in blood serum | 1.29e-03 | 12 | 133 | 2 | OBA_2045115 | |
| Disease | cholesteryl ester 20:2 measurement | 1.29e-03 | 12 | 133 | 2 | EFO_0021440 | |
| Disease | brain disease (is_implicated_in) | 1.29e-03 | 12 | 133 | 2 | DOID:936 (is_implicated_in) | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 1.50e-03 | 50 | 133 | 3 | EFO_0010732 | |
| Disease | ovary epithelial cancer (is_marker_for) | 1.52e-03 | 13 | 133 | 2 | DOID:2152 (is_marker_for) | |
| Disease | phosphatidylcholine 40:7 measurement | 1.52e-03 | 13 | 133 | 2 | EFO_0021477 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 1.52e-03 | 13 | 133 | 2 | OBA_2045159 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 1.52e-03 | 13 | 133 | 2 | OBA_2045174 | |
| Disease | phosphatidylcholine ether measurement | 1.52e-03 | 13 | 133 | 2 | EFO_0010227 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 1.59e-03 | 51 | 133 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | diglyceride measurement | 1.59e-03 | 51 | 133 | 3 | EFO_0010223 | |
| Disease | glucose measurement | 1.73e-03 | 380 | 133 | 7 | EFO_0004468 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.77e-03 | 14 | 133 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:1_20:2) in blood serum | 1.77e-03 | 14 | 133 | 2 | OBA_2045102 | |
| Disease | lysophosphatidylcholine 22:5 measurement | 1.77e-03 | 14 | 133 | 2 | EFO_0021462 | |
| Disease | diacylglycerol 38:4 measurement | 1.77e-03 | 14 | 133 | 2 | EFO_0020066 | |
| Disease | cis/trans-18:2 fatty acid measurement, trans fatty acid measurement | 2.04e-03 | 15 | 133 | 2 | EFO_0006821, EFO_0006824 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 2.04e-03 | 15 | 133 | 2 | OBA_2045131 | |
| Disease | phosphatidate measurement | 2.04e-03 | 15 | 133 | 2 | EFO_0020047 | |
| Disease | alkaline phosphatase measurement | NCOA2 STRA8 JAK1 PPP2R5C PTPRJ GLI3 TRIM8 SUGP1 TEKT1 MACF1 MYRF MUSK | 2.18e-03 | 1015 | 133 | 12 | EFO_0004533 |
| Disease | colorectal cancer (is_implicated_in) | 2.23e-03 | 121 | 133 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 2.30e-03 | 58 | 133 | 3 | DOID:10652 (biomarker_via_orthology) | |
| Disease | vitamin C measurement | 2.32e-03 | 16 | 133 | 2 | EFO_0600003 | |
| Disease | diacylglycerol 36:2 measurement | 2.32e-03 | 16 | 133 | 2 | EFO_0010355 | |
| Disease | phosphatidylcholine 38:6 measurement | 2.32e-03 | 16 | 133 | 2 | EFO_0010388 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 2.32e-03 | 16 | 133 | 2 | C0334634 | |
| Disease | migraine without aura, susceptibility to, 4 | 2.32e-03 | 16 | 133 | 2 | MONDO_0011847 | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 2.32e-03 | 16 | 133 | 2 | OBA_2045093 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 2.62e-03 | 17 | 133 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 2.94e-03 | 18 | 133 | 2 | OBA_2045155 | |
| Disease | diacylglycerol 36:3 measurement | 2.94e-03 | 18 | 133 | 2 | EFO_0020062 | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 3.28e-03 | 19 | 133 | 2 | OBA_2045140 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.28e-03 | 19 | 133 | 2 | C1333991 | |
| Disease | age at onset, smoking initiation | 3.28e-03 | 19 | 133 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | diacylglycerol 38:5 measurement | 3.28e-03 | 19 | 133 | 2 | EFO_0020067 | |
| Disease | diacylglycerol 38:3 measurement | 3.28e-03 | 19 | 133 | 2 | EFO_0020065 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.28e-03 | 19 | 133 | 2 | C2936783 | |
| Disease | phospholipids:total lipids ratio | 3.74e-03 | 227 | 133 | 5 | EFO_0020946 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 3.78e-03 | 69 | 133 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | bipolar I disorder | 3.87e-03 | 141 | 133 | 4 | EFO_0009963 | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 4.00e-03 | 21 | 133 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 4.00e-03 | 21 | 133 | 2 | OBA_2045104 | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 4.00e-03 | 21 | 133 | 2 | OBA_2045076 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 4.00e-03 | 21 | 133 | 2 | OBA_2045083 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DKQGVNSQKPCFFNS | 1181 | Q96QE3 | |
| GVFALNCFTKGQKNS | 16 | Q9NYP8 | |
| NSEFCGENLSKQKFT | 331 | Q6ZNE5 | |
| LNSEGNFCIQFKQSK | 106 | P28332 | |
| QTTDNQCAKIFGKGA | 496 | Q9Y3Q7 | |
| VGLAFAKANKQVCTD | 166 | P49747 | |
| FDDCTQQYKAEKQKG | 481 | Q14738 | |
| NQKLFDDCTQQFKAE | 401 | Q13362 | |
| EFGYNAETQKLLCKN | 181 | P53365 | |
| CGFVVYQNDKLFQSK | 321 | Q96K78 | |
| ELFGKFDQIAKANEC | 306 | P51828 | |
| FCNSENKVLKENADF | 1451 | Q6UB98 | |
| APQFGAQKCDNFAEK | 131 | Q9H6U6 | |
| NAVCAFYNKKVENFT | 1121 | Q8IZT6 | |
| QFRKTEQFCKSFENG | 76 | P23786 | |
| KAFAFQASQDKVCSI | 226 | Q9H000 | |
| ERKQGHNKISNFDCE | 766 | Q09MP3 | |
| KSDAGNLNFEFQVAK | 1336 | P49792 | |
| KNTNQCKGYGFVDFD | 96 | Q6XE24 | |
| FLVNVFGSCDKCFKQ | 6 | O14775 | |
| CFEKSEQVQGAQKQF | 481 | P23458 | |
| DGTCNTNFKKTQALE | 561 | Q96DU7 | |
| LQFCAGKALNDEFSK | 816 | O75747 | |
| DKAAQVFKLDCNSGT | 286 | O60330 | |
| DNQAKFTCKAGQLSA | 521 | O60500 | |
| FEAYFKKQQADSNCG | 1026 | Q12913 | |
| KKQQADSNCGFAEEY | 1031 | Q12913 | |
| VDSFQEKKIISFNGC | 81 | Q96R67 | |
| NQKFKCGEDNDGYSV | 96 | Q6NYC1 | |
| EGCNKAFSNASDRAK | 581 | P10071 | |
| VEQSFQCKVSFGNKR | 571 | Q86W28 | |
| DSQEAKGNKCSHFFQ | 626 | Q9UQF2 | |
| NSSFQLQADGKTCKD | 136 | Q07954 | |
| AQCNFFQDGLKAVES | 226 | O43150 | |
| SAFQVSACAFNKGKL | 206 | Q92598 | |
| VKEICFNSKENSNFS | 2406 | Q5CZC0 | |
| NTKEKVAFFVAHQCG | 96 | Q6PJ61 | |
| QSTACKKGEYNVQEA | 861 | Q9UMF0 | |
| QCGFDDTVKFLLKEN | 236 | P41247 | |
| KKQFIFSDGDCVDLN | 1926 | Q96JB1 | |
| AGCFKAIANVFQNRD | 1186 | O94915 | |
| CLGAVVNKVTQNFKF | 2091 | Q6KC79 | |
| VQDFKNLSGDCQDFR | 206 | O94854 | |
| KKAAFQDANVCLFVF | 581 | P49916 | |
| NKCKDFRQFFATSED | 1031 | Q9GZU2 | |
| KGGILANKQNCFDDF | 516 | P48147 | |
| CSKFNGFDQQTLQKI | 1066 | Q52LW3 | |
| NSKFLDFFSKAIQCA | 206 | Q13315 | |
| KCKNFALQTFEDVSQ | 186 | Q6TFL4 | |
| ALFDVKNNCKISADF | 401 | Q5JSL3 | |
| VNFKNFVCNIGEDAE | 226 | Q9H7D0 | |
| KKFCFSIQQGLNADY | 211 | Q8TCZ2 | |
| FKQKLCRAEQAFQAS | 456 | P49454 | |
| FFKDNTCLKNAIQAF | 331 | P56159 | |
| CDGQFRDQIKFENKV | 481 | Q9HC77 | |
| DAQCQVIFGSKAKAA | 521 | Q13443 | |
| AQCNFFQDGLKTADK | 246 | Q9ULH1 | |
| CGNEQFLDNSFEKVK | 571 | O43303 | |
| VNFDFDGAQKKLREC | 301 | P60228 | |
| AFDNFKEVCGEKQRF | 286 | Q96PY5 | |
| LKEAQRFFAQKFSCG | 141 | O43583 | |
| KNYFNCTNEGSKENL | 191 | Q96BH3 | |
| FQECKDLNAVAFRFK | 411 | P14735 | |
| LGAENAFNLFVCQKD | 966 | Q16531 | |
| NLKEFSQNGENFCKQ | 16 | Q8IVI9 | |
| CGSVKFEGNKQRDFN | 96 | Q9UKK6 | |
| NKTASGNVEAKVVCF | 31 | Q9BTC8 | |
| QRGVSINQFCKEFNE | 41 | Q9Y3B7 | |
| EAGDFICKAVNKTTN | 346 | Q8TB92 | |
| NCSEGIKNQKVFSAD | 31 | Q7RTR8 | |
| VGNYDQKKNIFQCVS | 316 | Q8NHS9 | |
| INKTGKAADLSFCQQ | 331 | Q9UPZ6 | |
| GSSNFCVKNIKQAEF | 101 | O43865 | |
| QCDVVDTAFKNGLKD | 256 | Q969V4 | |
| NKVDGSCKTFNDSEQ | 1106 | O75592 | |
| ADCNLNLKQKGYFFI | 321 | Q53GG5 | |
| SQGCNRKFDDQLKFV | 166 | Q13017 | |
| NKTANGNVEAKVVCF | 31 | Q13330 | |
| KGENFEVGSKVQFFC | 2276 | Q4LDE5 | |
| INFFKGLSCANTQVK | 291 | Q7Z7C7 | |
| GEKNNAFIVASFENK | 106 | Q14201 | |
| QKECKSLGFQHAAFE | 466 | O75969 | |
| NSKNQDVCHIAFGSK | 126 | Q6ZVT6 | |
| NTLNQFCNLAEKAGF | 266 | Q7Z624 | |
| SKVIQCFAETGQFQK | 486 | P53675 | |
| DFNTFLAQEGCTKGK | 201 | Q9UHD1 | |
| NFNDIDNFNFKPDKC | 56 | Q15596 | |
| REKSFQCNESGKAFN | 211 | Q96IR2 | |
| NKFANDGSFLQQFLK | 81 | Q8IWZ8 | |
| CAAQVDALNSQKKYF | 121 | O00584 | |
| QNKGHFLLKQDCDTF | 116 | Q8N8J6 | |
| GQVVCFDAKINFDDN | 251 | Q96I99 | |
| SCAIKNNKEAFSVVG | 156 | Q6NZY4 | |
| REKSFQCNESGKAFN | 211 | Q86XN6 | |
| NKCGKAFSQKENFLS | 86 | Q3ZCT1 | |
| NNCGKAFSFKSQLII | 531 | Q14587 | |
| GKVFQFLNAKCESAF | 26 | P83731 | |
| GEFEKVCSNDNKTFD | 106 | P09486 | |
| KKNDDALFVCGTNAF | 126 | Q9H2E6 | |
| FEAAKSCGDNIFQKA | 806 | Q6ZMY3 | |
| NFGQVKNCEVEQVKG | 196 | Q9UG56 | |
| ALEKNFKEISFCSQG | 311 | Q86TI0 | |
| VNENFCNEKEGAQFS | 626 | Q9Y263 | |
| DFAQKLGHNDFKCSN | 116 | Q8IY51 | |
| AQKKCQTLFGFDSDD | 1111 | Q8IZM8 | |
| KAGFAANFFKEVDEC | 566 | Q9Y6L7 | |
| KNCREAFTADGDQVF | 631 | Q96SB8 | |
| AQQEVGTCFLHFKDK | 101 | Q70Z35 | |
| LAAFCKKNLQDAENF | 731 | P11277 | |
| KKNLQDAENFFQFQG | 736 | P11277 | |
| QCLGFQEFQKDAKQA | 1166 | P11277 | |
| NFQCEKCKFSTQDVG | 206 | Q6AHZ1 | |
| REKSFQCNESGKAFN | 211 | Q6ZN06 | |
| DCRVNLQGKDFQFSE | 121 | Q9UJW7 | |
| NECGKAFYQKSQLTQ | 611 | Q06730 | |
| LDPANTQQFDDFKKC | 851 | Q6PJI9 | |
| QFVLAAGCAADQAKQ | 16 | Q8IYN6 | |
| EKSFQFNESGKSFNC | 211 | P0CJ79 | |
| KCEECGKAFNQFSNL | 486 | Q9H8G1 | |
| NECAKAFNQSSKLFD | 246 | Q6ZMS4 | |
| NECGKAFSQKQSLIA | 301 | Q5MCW4 | |
| CNECGKAFSQKQNFI | 496 | Q5MCW4 | |
| KCEECGKAFNQFSNL | 451 | Q96N22 | |
| DECGKTFQTKANLSQ | 326 | Q8TBZ5 | |
| QNGKCKQSFSDVAIF | 141 | Q9UIE0 | |
| CFQKIEKDIHGFQFQ | 86 | P17035 | |
| KFQTLEQAFECNKIG | 246 | Q9Y2H8 | |
| EQAFECNKIGKAFND | 251 | Q9Y2H8 | |
| EECGKAFNQSSNLTK | 541 | Q03923 | |
| KAKFNITGACLNDSD | 576 | Q9UPP1 | |
| REKSFQCNESGKAFN | 226 | A6NHJ4 | |
| EDQKQQQDPFCFSGK | 156 | P10072 | |
| NDCGKAFNVNAKLIQ | 311 | P17027 | |
| KAQAKFCSENAAQAL | 256 | Q9BZR9 | |
| DNVVFKFCEVAKENG | 656 | P11498 | |
| ECGKDFNQFSNLTKH | 326 | Q8NEM1 | |
| KCEECGKAFNQFANL | 351 | Q8NEM1 | |
| KCDQYGKNFSQSQDL | 261 | Q96NJ3 | |
| NDCGKAFSQNSVLIK | 391 | Q6ZS27 | |
| KFSNFCLAKVEGENL | 136 | Q96C45 | |
| AFGEQFDAKNKLTCS | 501 | Q96PN7 | |
| FSDFNAGAIKNKAQS | 456 | Q96NY9 | |
| QKEDAGQYRCVAKNS | 181 | O15146 | |
| NFSVGDDAFVCQKKN | 386 | Q9Y2G1 |